Prof. Dr. med. Mario Schiffer MBA

Direktor, Facharzt für Innere Medizin, Facharzt für Nephrologie, Hypertensiologe (DHL), Zusatzbezeichnung Transplantationsmedizin

Ulmenweg 18
91054 Erlangen

Gebäude
INZ

Raum
C2 562

Einrichtungen
Medizin 4
Transplantationszentrum

mario.schiffer(at)uk-erlangen.de

Lebenslauf, Veröffentlichungen und Auszeichnungen

Publikationen

Kollerits B, Kotsis F, Schneider MP, Schultheiss UT, Weissensteiner H, Schönherr S, Forer L, Meiselbach H, Wanner C, Eckardt KU, Dieplinger H, Kronenberg F, GCKD Investigators , Schiffer M, Prokosch HU, Bärthlein B, Beck A, Reis A, Ekici AB, Becker S, Alberth-Schmidt U, Weigel A, Marschall S, Schefler E, Walz G, Köttgen A, Meder S, Mitsch E, Reinhard U, Floege J, Saritas T, Gross A, Schaeffner E, Baid-Agrawal S, Theisen K, Haller H, Zeier M, Sommerer C, Aykac M, Wolf G, Busch M, Steiner A, Sitter T, Krane V, Börner-Klein A, Bauer B, Oefner P, Gronwald W, Schmid M, Nadal J: (2025) Association of Serum Afamin Concentrations With Kidney Failure in Patients With CKD: Findings From the German CKD Cohort Study. Am J Kidney Dis. 2025;85(4): 432-441.e1
Bytyqi V, Kannenkeril D, Striepe K, Bosch A, Karg MV, Schmid A, Schiffer M, Uder M, Schmieder RE: (2025) Predicting blood pressure response to renal denervation based on a new approach. J Hypertens. 2025;43(3): 413-419
Günes-Altan M, Schmid A, Ott C, Bosch A, Pietschner R, Schiffer M, Uder M, Schmieder RE, Kannenkeril D: (2024) Blood pressure reduction after renal denervation in patients with or without chronic kidney disease. Clin Kidney J. 2024;17(1):
Bosch A, Kannenkeril D, Ott C, Striepe K, Schiffer M, Schmieder RE: (2024) Relation between waist circumference and the renal hemodynamic in healthy individuals. Nutr Metab Cardiovasc Dis. 2024;34(3): 755-762
Guenes-Altan M, Schmid A, Kannenkeril D, Linz P, Ott C, Bosch A, Schiffer M, Uder M, Schmieder RE: (2024) Skin sodium content as a predictor of blood pressure response to renal denervation. Hypertens Res. 2024;47(2): 361-371
Catanese L, Siwy J, Wendt R, Amann K, Beige J, Hendry B, Mischak H, Mullen W, Paterson I, Schiffer M, Wolf M, Rupprecht H: (2024) Differentiating primary and secondary FSGS using non-invasive urine biomarkers. Clin Kidney J. 2024;17(2):
Assfalg V, Miller G, Stocker F, Hüser N, Hartmann D, Heemann U, Tieken I, Zanen W, Vogelaar S, Rosenkranz AR, Schneeberger S, Függer R, Berlakovich G, Ysebaert DR, Jacobs-Tulleneers-Thevissen D, Mikhalski D, van Laecke S, Kuypers D, Mühlfeld AS, Viebahn R, Pratschke J, Melchior S, Hauser IA, Jänigen B, Weimer R, Richter N, Foller S, Schulte K, Kurschat C, Harth A, Moench C, Rademacher S, Nitschke M, Krämer BK, Renders L, Koliogiannis D, Pascher A, Hoyer J, Weinmann-Menke J, Schiffer M, Banas B, Hakenberg O, Schwenger V, Nadalin S, Lopau K, Piros L, Nemes B, Szakaly P, Bouts A, Bemelman FJ, Sanders JS, de Vries APJ, Christiaans MHL, Hilbrands L, van Zuilen AD, Arnol M, Stippel D, Wahba R: (2024) Rescue Allocation Modes in Eurotransplant Kidney Transplantation: Recipient Oriented Extended Allocation Versus Competitive Rescue Allocation-A Retrospective Multicenter Outcome Analysis. Transplantation. 2024;108(5): 1200-1211
Duara J, Torres M, Gurumani M, Molina David J, Njeim R, Kim JJ, Mitrofanova A, Ge M, Sloan A, Müller-Deile J, Schiffer M, Merscher S, Fornoni A: (2024) Oxysterol-binding protein-like 7 deficiency leads to ER stress-mediated apoptosis in podocytes and proteinuria. Am J Physiol Renal Physiol. 2024;327(3): F340-F350
Visconti V, Wirtz S, Schiffer M, Müller-Deile J: (2024) Distinct Changes in Gut Microbiota of Patients With Kidney Graft Rejection. Transplant Direct. 2024;10(3):
Stamellou E, Nadal J, Hendry B, Mercer A, Seikrit C, Bechtel-Walz W, Schmid M, Moeller MJ, Schiffer M, Eckardt KU, Kramann R, Floege J, GCKD study investigators , Eckardt KU, Meiselbach H, Schneider MP, Schiffer M, Prokosch HU, Bärthlein B, Beck A, Reis A, Ekici AB, Becker S, Alberth-Schmidt U, Marschall S, Weigel A, Walz G, Köttgen A, Schultheiß UT, Kotsis F, Meder S, Mitsch E, Reinhard U, Floege J, Saritas T, Schaeffner E, Baid-Agrawal S, Theisen K, Schmidt-Ott K, Zeier M, Sommerer C, Aykac M, Wolf G, Busch M, Steiner A, Sitter T, Wanner C, Krane V, Bauer B, Kronenberg F, Raschenberger J, Kollerits B, Forer L, Schönherr S, Weissensteiner H, Oefner P, Gronwald W, Schmid M, Nadal J: (2024) Long-term outcomes of patients with IgA nephropathy in the German CKD cohort. Clin Kidney J. 2024;17(8):
Stamellou E, Nadal J, Hendry B, Mercer A, Bechtel-Walz W, Schiffer M, Eckardt KU, Kramann R, Moeller MJ, Floege J, GCKD study investigators , Eckardt KU, Meiselbach H, Schneider MP, Schiffer M, Prokosch HU, Bärthlein B, Beck A, Reis A, Ekici AB, Becker S, Alberth-Schmidt U, Marschall S, Weigel A, Walz G, Köttgen A, Schultheiß UT, Kotsis F, Meder S, Mitsch E, Reinhard U, Floege J, Saritas T, Schaeffner E, Baid-Agrawal S, Theisen K, Schmidt-Ott K, Zeier M, Sommerer C, Aykac M, Wolf G, Busch M, Steiner A, Sitter T, Wanner C, Krane V, Bauer B, Kronenberg F, Raschenberger J, Kollerits B, Forer L, Schönherr S, Weissensteiner H, Oefner P, Gronwald W, Schmid M, Nadal J: (2024) Long-term outcomes of adults with FSGS in the German Chronic Kidney Disease cohort. Clin Kidney J. 2024;17(7):
Steinbrenner I, Kotsis F, Kosch R, Meiselbach H, Bärthlein B, Stockmann H, Lipovsek J, Zacharias HU, Altenbuchinger M, Dienemann T, Wytopil M, Bächle H, Sommerer C, Titze S, Weigel A, Weissensteiner H, Schönherr S, Forer L, Kurz NS, Menne J, Schlieper G, Schneider MP, Schaeffner E, Kielstein JT, Sitter T, Floege J, Wanner C, Kronenberg F, Köttgen A, Busch M, Krane V, Schmid M, Eckardt KU, Schultheiss UT, GCKD Investigators , Eckardt KU, Meiselbach H, Schneider MP, Schiffer M, Prokosch HU, Bärthlein B, Beck A, Reis A, Ekici AB, Becker S, Alberth-Schmidt U, Weigel A, Marschall S, Schefler E, Walz G, Köttgen A, Schultheiß UT, Kotsis F, Meder S, Mitsch E, Reinhard U, Floege J, Saritas T, Groß A, Schaeffner E, Baid-Agrawal S, Theisen K, Schmidt-Ott K, Zeier M, Sommerer C, Aykac M, Wolf G, Busch M, Steiner A, Sitter T, Wanner C, Krane V, Börner-Klein A, Bauer B, Kronenberg F, Raschenberger J, Kollerits B, Forer L, Schönherr S, Weissensteiner H, Oefner P, Gronwald W, Schmid M, Nadal J: (2024) Interactive exploration of adverse events and multimorbidity in CKD. Nephrol Dial Transplant. 2024;39(12): 2016-2024
Pilgram L, Meurers T, Malin B, Schaeffner E, Eckardt KU, Prasser F, GCKD Investigators , Meiselbach H, P Schneider M, Schiffer M, Prokosch HU, Bärthlein B, Beck A, Kraska D, Reis A, B Ekici A, Becker S, Alberth-Schmidt U, Marschall S, Schefler E, Weigel A, Walz G, Köttgen A, T Schultheiß U, Kotsis F, Meder S, Mitsch E, Reinhard U, Floege J, Saritas T, Gross A, Baid-Agrawal S, Theisen K, Schmidt-Ott K, Martin Z, Sommerer C, Aykac M, Wolf G, Busch M, Paul R, Sitter T, Wanner C, Krane V, Börner-Klein A, Bauer B, Kronenberg F, Raschenberger J, Kollerits B, Forer L, Schönherr S, Weissensteiner H, Oefner P, Gronwald W, Schmid M, Nadal J: (2024) The Costs of Anonymization: Case Study Using Clinical Data. J Med Internet Res. 2024;26():
Kollerits B, Gruber S, Steinbrenner I, Schwaiger JP, Weissensteiner H, Schönherr S, Forer L, Kotsis F, Schultheiss UT, Meiselbach H, Wanner C, Eckardt KU, Kronenberg F, GCKD Investigators , Schneider MP, Schiffer M, Prokosch HU, Bärthlein B, Beck A, Reis A, Ekici AB, Becker S, Alberth-Schmidt U, Weigel A, Marschall S, Schefler E, Walz G, Köttgen A, Schultheiß UT, Meder S, Mitsch E, Reinhard U, Floege J, Saritas T, Gross A, Schaeffner E, Baid-Agrawal S, Theisen K, Haller H, Zeier M, Sommerer C, Aykac M, Wolf G, Busch M, Steiner A, Sitter T, Krane V, Börner-Klein A, Bauer B, Oefner P, Gronwald W, Schmid M, Nadal J: (2024) Apolipoprotein A-IV concentrations and cancer in a large cohort of chronic kidney disease patients: results from the GCKD study. BMC Cancer. 2024;24(1):
Kraus A, Skoczynski K, Brötsch M, Burzlaff N, Leipziger J, Schiffer M, Büttner-Herold M, Buchholz B: (2024) P2Y2R and Cyst Growth in Polycystic Kidney Disease. J Am Soc Nephrol. 2024;35(10): 1351-1365
Wopperer FJ, Olinger E, Wiesener A, Broeker KAE, Knaup KX, Schaefer JT, Galiano M, Schneider K, Schiffer M, Genomics England Research Consortium , Büttner-Herold M, Reis A, Schmieder R, Pasutto F, Hilgers KF, Poglitsch M, Ziegler C, Shoemaker R, Sayer JA, Wiesener MS: (2024) Progressive Kidney Failure by Angiotensinogen Inactivation in the Germline. Hypertension. 2024;81(9): 1857-1868
Günes-Altan M, Bosch A, Striepe K, Bramlage P, Schiffer M, Schmieder RE, Kannenkeril D: (2024) Is GFR decline induced by SGLT2 inhibitor of clinical importance? Cardiovasc Diabetol. 2024;23(1):
Kopp C, Kittler L, Linz P, Kannenkeril D, Horn S, Chazot C, Schiffer M, Uder M, Nagel AM, Dahlmann A: (2024) Modification of Dialysate Na+ Concentration but not Ultrafiltration or Dialysis Treatment Time Affects Tissue Na+ Deposition in Patients on Hemodialysis. Kidney Int Rep. 2024;9(5): 1310-1320
Kannenkeril D, Bosch A, Kolwelter J, Striepe K, Berner L, Pietschner R, Ott C, Schiffer M, Achenbach S, Schmieder RE: (2024) PCSK-9-inhibitor therapy improves endothelial function in high-risk patients with cardiovascular disease. Clin Res Cardiol. 2024;():
Bosch A, Rauh M, Striepe K, Schiffer M, Schmieder RE, Kannenkeril D: (2024) Renal adaptation in pre-obesity patients with hypertension. J Hypertens. 2024;42(11): 1958-1965
Wei X, Weber S, Yin D, Allabauer I, Jobst-Schwan T, Wiesener M, Schiffer M, Dudziak D, Lehmann CHK, Woelfle J, Hoerning A: (2024) Pharmacodynamic Effect of mTOR Inhibition-based Immunosuppressive Therapy on T- and B-cell Subsets After Renal Transplantation. Transplant Direct. 2024;10(7):
Kurzhagen JT, Titze S, Büschges-Seraphin B, Schiffer M, Schneider MP, Eckardt KU, Hilgers KF: (2024) Spot urinary sodium in CKD patients: correlation with 24h-excretion and evaluation of commonly used prediction equations. BMC Nephrol. 2024;25(1):
Fueermann F, Heller K, Pavel M, Herbst L, Grützmann R, Schiffer M: (2024) Pancreas transplantation as rescue therapy in a patient with type 1 diabetes and concurrent subcutaneous insulin resistance. Am J Transplant. 2024;24(11): 2125-2128
Skoczynski K, Kraus A, Daniel C, Büttner-Herold M, Amann K, Schiffer M, Hermann K, Herrnberger-Eimer L, Tamm ER, Buchholz B: (2024) The extracellular matrix protein fibronectin promotes metanephric kidney development. Pflugers Arch. 2024;476(6): 963-974
Pape L, DeZwaan M, Nöhre M, Klewitz F, Kyaw Tha Tun E, Prüfe J, Schiffer L, Gertges R, Schieffer E, Albrecht A, Boeck HT, Kliem V, Wolff JK, Ludolph P, Talamo J, Nolting HD, Lieb M, Erim Y, Krusemark H, Gefeller O, Kaiser I, Tegtbur U, Schiffer M, KTx360°-Study Group , Anders P, Bauer-Hohmann M, Boyen J, Dehn-Hindenberg A, Frömel M, Falkenstern J, Kleemann J, Haffner D, Hartleib-Otto M, Haller H, Hellrung N, Kanzelmeyer N, Lerch C, Mazhari AL, Meißmer M, Pfeiffer R, Reber S, Schelper S, Wenzel M: (2024) A multimodal aftercare intervention improves the outcome after kidney transplantation - results of the KTx360° aftercare program using claims data. EClinicalMedicine. 2024;73():
Gwinner W, Anaokar S, Blogg M, Hermann B, Repetur CDP, Schiffer M: (2024) Long-Term Outcomes with Prolonged-Release Tacrolimus in Kidney Transplantation: A Retrospective Real-World Data Analysis. Ann Transplant. 2024;29():
Krusemark H, Schiffer M: (2024) [Comprehensive care for kidney transplantation-optimization of interdisciplinary support before and after kidney transplantation]. Urologie. 2024;63(4): 333-340
Bytyqi V, Kannenkeril D, Striepe K, Bosch A, Schiffer M, Schmid A, Uder M, Schmieder RE: (2024) BLOOD PRESSURE RESPONDERS TO RENAL DENERVATION BASED ON A NEW DEFINITION J Hypertens. 2024;42 Suppl 1():
Bosch A, Schmid A, Kannenkeril D, Harazny J, Ott C, Striepe K, Guenes-altan M, Roth H, Schiffer M, Uder M, Schmieder R: (2024) WHY HAPPENS A PROGRESSIVE DECREASE OF BLOOD PRESSURE AFTER RENAL DENERVATION J Hypertens. 2024;42 Suppl 1():
Kannenkeril D, Guenes-altan M, Bosch A, Striepe K, Heller K, Schiffer M, Janka R, Amann K, Schmieder RE: (2024) INCREASE IN ARTERIAL STIFFNESS IN LIVING KIDNEY DONORS AFTER RENAL DONATION J Hypertens. 2024;42 Suppl 1():
Rodionova K, Ditting T, Holzmann K, Bach F, Cordasic N, Hilgers KF, Linz P, Schiffer M, Amann K, Veelken R: (2024) SIGNIFICANCE OF THE NAV 1.8. VOLTAGE-GATED, TETRODOTOXIN-RESISTANT SODIUM CHANNEL FOR THE RENAL SENSORY INNERVATION IN MICE AND RATS J Hypertens. 2024;42 Suppl 1():
Rodionova K, Ditting T, Cordasic N, Hilgers KF, Schiffer M, Amann K, Ditting T: (2024) A NOVEL METHOD FOR THE ANALYSIS OF RENAL SYMPATHETIC NERVE ACTIVITY FROM MULTI-FIBER NERVE RECORDINGS J Hypertens. 2024;42 Suppl 1():
Wei XY, Weber S, Yin DC, Allabauer I, Jobst-Schwan T, Wiesener M, Schiffer M, Dudziak D, Lehmann CHK, Woelfle J, Hoerning A: (2024) Pharmacodynamic effect of mTOR inhibition-based immunosuppressive therapy on T and B cell subsets after renal transplantation Eur J Immunol. 2024;54 Suppl 1(): 1558-1558
Schmieder R, Kannenkeril D, Boehm M, Ewen S, Mahfoud F, Rump C, Stegbauer J, van der Giet M, Schiffer M, Veelken R, Uder M, Schmid A: (2024) Ultrasound-Based Renal Denervation Reduces Blood Pressure in Patients With Chronic Kidney Disease: Results of a Multicenter Prospective Randomized Sham-Controlled Blinded Investigator Initiated Trial J Am Coll Cardiol. 2024;84 Suppl S(18): B159-B159
Schmieder R, Kannenkeril D, Boehm M, Mahfoud F, Rump LC, Stegbauer J, Van Der Giet M, Schiffer M, Veelken R, Uder M, Schmid A: (2024) EFFECT OF RENAL DENERVATION ON BLOOD PRESSURE IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND UNCONTROLLED HYPERTENSION: RESULTS OF A PROSPECTIVE RANDOMIZED SHAM-CONTROLLED STUDY J Hypertens. 2024;42 Suppl 1():
Visconti V, Mueller-Deile J, Schiffer M, Wirtz S: (2024) Distinct changes in gut microbiota of patients with kidney graft rejection Nephrol Dial Transplant. 2024;39 Suppl _1():
Tati R, Mueller-Deile J, Walentinsson A, Sopel N, Lassen E, Ebefors K, Soederberg M, Daniel C, Hansen PBL, Schiffer M, Nystrom J, Buvall L: (2024) MiR-200b induces ZEB1 mediated upregulation of Matriptase and affects expression of podocin Nephrol Dial Transplant. 2024;39 Suppl 1(): I805-I805
Visconti V, Mueller-Deile J, Schiffer M, Wirtz S: (2024) Distinct changes in gut microbiota of patients with kidney graft rejection Nephrol Dial Transplant. 2024;39 Suppl 1(): I178-I181
Noehre M, Klewitz F, Bauer-Hohmann M, Tegtbur U, Erim Y, Pape L, Schiffer M, de Zwaan M: (2024) Frequency and correlates of non-adherence in a large sample of patients after kidney transplantation: A KTx360° substudy Psychother Psychosom. 2024;93 Suppl 1(): 95-96
Kern J, Thiagarajan S, Uderhardt S, Sopel N, Schiffer M, Mueller-Deile J: (2024) Intranephron Cross-Talk through Exosomes J Am Soc Nephrol. 2024;35 Suppl S(10):
Rose V, Fink D, Krueger R, Schoedel J, Schiffer M, Mueller-Deile J: (2024) Ex Vivo-Derived Human-Induced Pluripotent Stem Cell (hiPSC) Podocytes from a Patient with Genetic Focal Segmental Glomerulosclerosis with an INF2 Mutation J Am Soc Nephrol. 2024;35 Suppl S(10):
Bakhshiyeva E, Kranefuss M, Schiffer M, Willam C, Brox R, Kurzhagen JT: (2024) Lymphocyte Immune Assays for the Management of Immunosuppression of Kidney Transplant Patients in Sepsis J Am Soc Nephrol. 2024;35 Suppl S(10):
Pollinger L, Greve JN, Kaliman S, Abuhattum S, Kraeter M, Wiesener A, Pasutto F, Grosch M, Haak JR, Kolb C, Daniel C, Amann KU, Schiffer M, Manstein DJ, Wiesener MS, Jobst-Schwan T: (2024) The Novel MYH9 Variant, c.1270C>G, p.Arg424Gly, Causes Epstein-Fechtner Syndrome by the Modification of Nonmuscular Myosin IIA Contraction J Am Soc Nephrol. 2024;35 Suppl S(10):
Schwarz H, Knaup KX, Wopperer FJ, Schiffer M, Buettner MJ, Amann KU, Wiesener MS: (2024) Characterization and Regulation of the Disease-Causing Mucin 1 Frameshift Protein in Patient-Derived Cells Affected by Autosomal Dominant Tubulointerstitial Kidney Disease (ADTKD)-MUC1 J Am Soc Nephrol. 2024;35 Suppl S(10):
Hartner A, Cordasic N, Schiffer M, Veelken R, Amann KU, Daniel C, Hilgers KF: (2024) Matrix Metalloprotease Activity in Vascular Lesions of Malignant Hypertensive Rats J Am Soc Nephrol. 2024;35 Suppl S(10):
Hutter E, Ditting T, Meissner C, Cordasic N, Linz P, Hilgers KF, Schiffer M, Amann KU, Veelken R, Rodionova K: (2024) Impaired Long-Term and Short-Term Control of Sympathetic Nerve Activity in Nonhypertensive Dahl S Salt-Sensitive Rats J Am Soc Nephrol. 2024;35 Suppl S(10):
Kannenkeril D, Schmieder RE, Boehm M, Mahfoud F, Rump LC, Stegbauer J, van der Giet M, Schiffer M, Veelken R, Uder M, Schmid A: (2024) Renal Denervation Is Effective in Reducing Blood Pressure in Patients with CKD: Results of a Multicenter, Prospective, Randomized, Sham-Controlled, Blinded, Investigator-Initiated Trial J Am Soc Nephrol. 2024;35 Suppl S(10):
Rodionova K, Hutter E, Ditting T, Cordasic N, Hilgers KF, Linz P, Schiffer M, Schmieder RE, Amann KU, Veelken R: (2024) Increased Blood Pressure in Mice with Impaired Function of Afferent Renal Nerves Due to Lack of Sodium Nav1.8 Channels J Am Soc Nephrol. 2024;35 Suppl S(10):
Kannenkeril D, Guenes-Altan M, Bosch A, Striepe K, Schiffer M, Amann KU, Schmieder RE: (2024) Increase in Arterial Stiffness in Living Kidney Donors after Kidney Donation J Am Soc Nephrol. 2024;35 Suppl S(10):
Rumpff C, Lieb V, Wullich B, Schiffer M, Kunath F, Apel H: (2024) Kidney transplantation in prostate cancer patients after local therapy with curative intent: a systematic review. World J Urol. 2024;42(1):
Guenes-Altan M, Schmid A, Kannenkeril D, Linz P, Ott C, Bosch A, Schiffer M, Uder M, Schmieder R: (2023) SKIN SODIUM CONTENT AS A PREDICTOR OF BLOOD PRESSURE RESPONSE TO RENAL DENERVATION J Hypertens. 2023;41 Suppl 3(): E250-E251
Guenes-Altan M, Bosch A, Striepe K, Schiffer M, Bramlage P, Schmieder RE, Kannenkeril D: (2023) IS GFR DECLINE INDUCED BY SGLT-2 INHIBITOR OF CLINICAL IMPORTANCE? Nephrol Dial Transplant. 2023;38 Suppl 1(): I87-I88
Gunes-Altan M, Schmid A, Ott C, Bosch A, Schiffer M, Uder M, Schmieder R, Kannenkeril D: (2023) BLOOD PRESSURE REDUCTION AFTER RENAL DENERVATION IN PATIENTS WITH OR WITHOUT CHRONIC KIDNEY DISEASE: THE ERLANGER EXPERIENCE J Hypertens. 2023;41 Suppl 3(): E256-E256
Kannenkeril D, Bosch A, Kolwelter J, Striepe K, Pietschner R, Ott C, Schiffer M, Achenbach S, Schmieder RE: (2023) PCSK-9-INHIBITOR THERAPY IMPROVES ENDOTHELIAL FUNCTION IN HIGH-RISK PATIENTS WITH CARDIOVASCULAR DISEASE J Hypertens. 2023;41 Suppl 1(): E293-E293
Schmid A, Ott C, Bosch A, Schiffer M, Uder M, Schmieder RE, Kannenkeril D: (2023) BLOOD PRESSURE REDUCTION AFTER RENAL DENERVATION IN PATIENTS WITH OR WITHOUT CHRONIC KIDNEY DISEASE: THE ERLANGER EXPERIENCE J Hypertens. 2023;41 Suppl 1(): E484-E484
Rodionova K, Veelken R, Cordasic N, Hilgers KF, Schmieder RE, Schiffer M, Amann K, Ditting T: (2023) A Novel Method For The Analysis Of Renal Sympathetic Nerve Activity From Multi-fiber Nerve Recordings Hypertension. 2023;80 Suppl 1():
Rodionova K, Ditting T, Lindner S, Linz PR, Cordasic N, Hilgers KF, Schiffer M, Schmieder RE, Amann K, Veelken R: (2023) The Positive Effect Of Renal Denervation Persists Even Through Regrowth Of Afferent Axons Improving Renal Afferent Nerve Activity During High Sodium Intake In Rats Hypertension. 2023;80 Suppl 1():
Rodionova K, Ditting T, Holzmann K, Bach F, Linz PR, Hilgers KF, Schmieder RE, Schiffer M, Amann K, Veelken R: (2023) Significance Of The Nav 1.8. Voltage-gated, Tetrodotoxin-resistant Sodium Channel For The Renal Sensory Innervation In Mice And Rats Hypertension. 2023;80 Suppl 1():
Rodionova K, Ditting T, Hilgers KF, Linz P, Schmieder RE, Ott C, Schiffer M, Amann K, Veelken R: (2023) EMPAGLIFLOZIN IMPROVES IMPAIRED SENSITIVITY OF AFFERENT NEURONS WITH RENAL AXONS J Hypertens. 2023;41 Suppl 3(): E75-E75
Rodionova K, Ditting T, Linz P, Hilgers KF, Ott C, Schmieder RE, Schiffer M, Amann K, Veelken R: (2023) HIGH SODIUM INTAKE - EFFECTS ON AFFERENT RENAL NERVE ACTIVITY J Hypertens. 2023;41 Suppl 3(): E75-E75
Wopperer F, Olinger E, Knaup K, Wiesener A, Broeker K, Schiffer M, Hilgers K, Pasutto F, Sayer J, Wiesener M: (2023) RECOGNITION OF RENAL TUBULAR DYSGENESIS IN ADOLESCENT CKD BY BIALLELIC AGT VARIANTS REQUIRED BROAD GENETIC ANALYSIS Nephrol Dial Transplant. 2023;38 Suppl 1(): I211-I211
Guenes-Altan M, Bosch A, Striepe K, Schiffer M, Bramlage P, Schmieder RE, Kannenkeril D: (2023) Is GFR decline induced by SGLT-2 inhibitor of clinical importance? Diabetologia. 2023;66 Suppl 1(SUPPL 1): S352-S352
Rose V, Sopel N, Miedl D, Krueger R, Kraus A, Schiffer M, Muller-Deile J: (2023) PATIENT-SPECIFIC HUMAN INDUCED PLURIPOTENT STEM CELL (HIPSC)-DERIVED PODOCYTES Nephrol Dial Transplant. 2023;38 Suppl 1(): I253-I253
Ekici A, Knaup K, Schneider K, Wopperer F, Wiesener A, Dieterle A, Schiffer M, Reis A, Pasutto F, Wiesener M: (2023) WHENWHOLE EXOME SEQUENCING IS NOT GOOD ENOUGH: BACK TO THE ROOTS OR FORWARD TO THE FUTURE Nephrol Dial Transplant. 2023;38 Suppl 1(): I224-I225
Knaup K, Schneider K, Rehrl S, Wopperer F, Schiffer M, Buettner-Herold M, Amann K, Schloetzer-Schrehardt U, Wiesener M: (2023) CHARACTERIZATION AND REGULATION OF THE PATHOGENIC MUCIN 1 FRAMESHIFT PROTEIN IN PATIENT DERIVED CELLS AFFECTED BY ADTKD-MUC1 Nephrol Dial Transplant. 2023;38 Suppl 1(): I210-I210
Loderbauer L, Schneider K, Knaup K, Wopperer F, Schiffer M, Amann K, Broeker K, Buettner-Herold M, Wiesener M: (2023) EXPRESSION OF THE COLLAGEN IV α345MOLECULE ALONG THE RENAL TUBULE IN HEALTH AND DISEASE Nephrol Dial Transplant. 2023;38 Suppl 1(): I3-I3
Stamellou E, Nadal J, Seikrit C, Hendry B, Mercer A, Schmidt M, Moeller MJ, Schiffer M, Eckardt KU, Floege J: (2023) THE NATURAL HISTORY OF FSGS IN THE GERMAN CHRONIC KIDNEY DISEASE (GCKD) COHORT Nephrol Dial Transplant. 2023;38 Suppl 1(): I386-I387
Stamellou E, Nadal J, Seikrit C, Hendry B, Mercer A, Moeller MJ, Schmidt M, Schiffer M, Eckardt KU, Floege J: (2023) THE NATURAL HISTORY OF IGA NEPHROPATHY IN THE GERMAN CHRONIC KIDNEY DISEASE (GCKD) COHORT Nephrol Dial Transplant. 2023;38 Suppl 1(): I373-I373
Mueller DIH, Achenbach S, Kopp C, Schiffer M, Bittner D: (2023) IMMUNOADSORPTION IN NONISCHEMIC CARDIOMYOPATHY - INSIGHTS FROM A REAL-WORLD CLINICAL SCENARIO J Am Coll Cardiol. 2023;81 Suppl A(8): 312-312
Steinbrenner I, Sekula P, Kotsis F, von Cube M, Cheng Y, Nadal J, Schmid M, Schneider MP, Krane V, Nauck M, Eckardt KU, Schultheiss UT, GCKD investigators , Eckardt KU, Meiselbach H, Schneider MP, Schiffer M, Prokosch HU, Bärthlein B, Beck A, Reis A, Ekici AB, Becker S, Becker-Grosspitsch D, Alberth-Schmidt U, Hausknecht B, Weigel A, Walz G, Köttgen A, Schultheiß UT, Kotsis F, Meder S, Mitsch E, Reinhard U, Floege J, Saritas T, Schaeffner E, Baid-Agrawal S, Theisen K, Haller H, Menne J, Zeier M, Sommerer C, Theilinger J, Wolf G, Busch M, Paul R, Sitter T, Wanner C, Krane V, Börner-Klein A, Bauer B, Kronenberg F, Raschenberger J, Kollerits B, Forer L, Schönherr S, Weissensteiner H, Oefner P, Gronwald W, Schmid M, Nadal J: (2023) Association of osteopontin with kidney function and kidney failure in chronic kidney disease patients: the GCKD study. Nephrol Dial Transplant. 2023;38(6): 1430-1438
Moest T, Jahn AE, Heller K, Schiffer M, Adler W, Rohde M, Weber M, Kesting MR, Lutz R: (2023) Peculiarities in the panoramic radiograph of patients with secondary hyperparathyroidism due to terminal renal disease: a radiologic controlled comparative study. Oral Radiol. 2023;39(1): 125-132
Kolwelter J, Kannenkeril D, Linz P, Jung S, Nagel AM, Bosch A, Ott C, Bramlage P, Nöh L, Schiffer M, Uder M, Achenbach S, Schmieder RE: (2023) The SGLT2 inhibitor empagliflozin reduces tissue sodium content in patients with chronic heart failure: results from a placebo-controlled randomised trial. Clin Res Cardiol. 2023;112(1): 134-144
Pietschner R, Bosch A, Kannenkeril D, Striepe K, Schiffer M, Achenbach S, Schmieder RE, Kolwelter J: (2023) Is vascular remodelling in patients with chronic heart failure exaggerated? ESC Heart Fail. 2023;10(1): 245-254
Bosch A, Poglitsch M, Kannenkeril D, Kolwelter J, Striepe K, Ott C, Rauh M, Schiffer M, Achenbach S, Schmieder RE: (2023) Angiotensin pathways under therapy with empagliflozin in patients with chronic heart failure. ESC Heart Fail. 2023;10(3): 1635-1642
Staef M, Ott C, Kannenkeril D, Striepe K, Schiffer M, Schmieder RE, Bosch A: (2023) Determinants of arterial stiffness in patients with type 2 diabetes mellitus: a cross sectional analysis. Sci Rep. 2023;13(1):
Hartner A, Dambietz T, Cordasic N, Willam C, Burzlaff N, Brötsch M, Daniel C, Schiffer M, Amann K, Veelken R, Schley G, Hilgers KF: (2023) No benefit of HIF prolyl hydroxylase inhibition for hypertensive renal damage in renovascular hypertensive rats. Front Physiol. 2023;14():
Lale N, Ditting T, Hilgers KF, Linz P, Ott C, Schmieder RE, Schiffer M, Amann K, Veelken R, Rodionova K: (2023) Afferent neurons of the kidney with impaired firing pattern in inflammation - role of sodium currents? Pflugers Arch. 2023;475(11): 1329-1342
Pickny L, Hindermann M, Ditting T, Hilgers KF, Linz P, Ott C, Schmieder RE, Schiffer M, Amann K, Veelken R, Rodionova K: (2023) Myocardial infarction with a preserved ejection fraction-the impaired function of the cardio-renal baroreflex. Front Physiol. 2023;14():
Naas S, Krüger R, Knaup KX, Naas J, Grampp S, Schiffer M, Wiesener M, Schödel J: (2023) Hypoxia controls expression of kidney-pathogenic MUC1 variants. Life Sci Alliance. 2023;6(9):
Grampp S, Kraus A, Skoczynski K, Schiffer M, Krüger R, Naas S, Schödel J, Buchholz B: (2023) Hypoxia induces polycystin-1 expression in the renal epithelium. R Soc Open Sci. 2023;10(5):
Grampp S, Krüger R, Lauer V, Uebel S, Knaup KX, Naas J, Höffken V, Weide T, Schiffer M, Naas S, Schödel J: (2023) Hypoxia hits APOL1 in the kidney. Kidney Int. 2023;104(1): 53-60
Kraus A, Rose V, Krüger R, Sarau G, Kling L, Schiffer M, Christiansen S, Müller-Deile J: (2023) Characterizing Intraindividual Podocyte Morphology In Vitro with Different Innovative Microscopic and Spectroscopic Techniques. Cells. 2023;12(9):
Rederer A, Rose V, Krüger R, Schmittutz L, Swierzy I, Fischer L, Thievessen I, Bauer J, Friedrich O, Schiffer M, Müller-Deile J: (2023) Partner, Neighbor, Housekeeper and Dimension: 3D versus 2D Glomerular Co-Cultures Reveal Drawbacks of Currently Used Cell Culture Models. Int J Mol Sci. 2023;24(12):
Sommerer C, Müller-Krebs S, Nadal J, Schultheiss UT, Friedrich N, Nauck M, Schmid M, Nußhag C, Reiser J, Eckardt KU, Zeier M, Hayek SS, German Chronic Kidney Disease Investigators , Eckardt KU, Meiselbach H, Schneider MP, Schiffer M, Prokosch HU, Bärthlein B, Beck A, Kraska D, Reis A, Ekici AB, Becker S, Alberth-Schmidt U, Marschall S, Schefler E, Weigel A, Walz G, Köttgen A, Schultheiß UT, Kotsis F, Meder S, Mitsch E, Reinhard U, Floege J, Saritas T, Schaeffner E, Baid-Agrawal S, Theisen K, Schmidt-Ott K, Zeier M, Sommerer C, Aykac M, Wolf G, Busch M, Paul R, Sitter T, Wanner C, Krane V, Börner-Klein A, Bauer B, Kronenberg F, Raschenberger J, Kollerits B, Forer L, Schönherr S, Weissensteiner H, Oefner P, Gronwald W, Schmid M, Nadal J: (2023) Prospective Cohort Study of Soluble Urokinase Plasminogen Activation Receptor and Cardiovascular Events in Patients With CKD. Kidney Int Rep. 2023;8(11): 2265-2275
Schneider MP, Schmid M, Nadal J, Krane V, Saritas T, Busch M, Schultheiss UT, Meiselbach H, Friedrich N, Nauck M, Floege J, Kronenberg F, Wanner C, Eckardt KU, GCKD study investigators , Eckardt KU, Meiselbach H, Schiffer M, Prokosch HU, Bärthlein B, Beck A, Reis A, Ekici AB, Becker S, Becker-Grosspitsch D, Alberth-Schmidt U, Hausknecht B, Weigel A, Walz G, Köttgen A, Schultheiß UT, Kotsis F, Meder S, Mitsch E, Reinhard U, Floege J, Saritas T, Schaeffner E, Baid-Agrawal S, Theisen K, Haller H, Menne J, Zeier M, Sommerer C, Theilinger J, Wolf G, Busch M, Paul R, Sitter T, Wanner C, Krane V, Börner-Klein A, Bauer B, Kronenberg F, Raschenberger J, Kollerits B, Forer L, Schönherr S, Weissensteiner H, Oefner P, Gronwald W, Schmid M, Nadal J: (2023) Copeptin, Natriuretic Peptides, and Cardiovascular Outcomes in Patients With CKD: The German Chronic Kidney Disease (GCKD) Study. Kidney Med. 2023;5(11):
Reimer KC, Nadal J, Meiselbach H, Schmid M, Schultheiss UT, Kotsis F, Stockmann H, Friedrich N, Nauck M, Krane V, Eckardt KU, Schneider MP, Kramann R, Floege J, Saritas T, GCKD study investigators , Schiffer M, Prokosch HU, Bärthlein B, Beck A, Reis A, Ekici AB, Becker S, Alberth-Schmidt U, Weigel A, Marschall S, Schefler E, Walz G, Köttgen A, Kotsis F, Meder S, Mitsch E, Reinhard U, Schaeffner E, Baid-Agrawal S, Theisen K, Schmidt-Ott K, Zeier M, Sommerer C, Aykac M, Wolf G, Paul R, Börner-Klein A, Bauer B, Raschenberger J, Kollerits B, Forer L, Schönherr S, Weissensteiner H, Oefner P, Gronwald W: (2023) Association of mineral and bone biomarkers with adverse cardiovascular outcomes and mortality in the German Chronic Kidney Disease (GCKD) cohort. Bone Res. 2023;11(1):
Cejka V, Störk S, Nadal J, Schmid M, Sommerer C, Sitter T, Meiselbach H, Busch M, Schneider MP, Saritas T, Schultheiss UT, Kotsis F, Wanner C, Eckardt KU, Krane V, GCKD Study Investigators , Eckardt KU, Meiselbach H, Schneider MP, Schiffer M, Prokosch HU, Bärthlein B, Beck A, Reis A, Ekici AB, Becker S, Becker-Grosspitsch D, Alberth-Schmidt U, Hausknecht B, Weigel A, Walz G, Köttgen A, Schultheiß UT, Kotsis F, Meder S, Mitsch E, Reinhard U, Floege J, Saritas T, Schaeffner E, Baid-Agrawal S, Theisen K, Haller H, Zeier M, Sommerer C, Theilinger J, Wolf G, Busch M, Paul R, Sitter T, Wanner C, Krane V, Börner-Klein A, Bauer B, Kronenberg F, Raschenberger J, Kollerits B, Forer L, Schönherr S, Weissensteiner H, Oefner P, Gronwald W, Schmid M, Nadal J: (2023) Differential Prognostic Utility of Adiposity Measures in Chronic Kidney Disease. J Ren Nutr. 2023;33(4): 546-554
Naas S, Schiffer M, Schödel J: (2023) Hypoxia and renal fibrosis. Am J Physiol Cell Physiol. 2023;325(4): C999-C1016
Schaefer JT, Schulz-Heise S, Rueckel A, Rauh M, Juengert J, Galiano M, Meier N, Woelfle J, Schiffer M, Hoerning A: (2023) Frequency and impact of enteric hyperoxaluria in pediatric short bowel syndrome: a retrospective single centre study. Front Pediatr. 2023;11():
de Fijter J, Dreyer G, Mallat M, Budde K, Pratschke J, Klempnauer J, Zeier M, Arns W, Hugo C, Rump LC, Hauser I, Schenker P, Schiffer M, Grimm MO, Kliem V, Olbricht CJ, Pisarski P, Banas B, Suwelack B, Hakenberg O, Berlakovich G, Schneeberger S, van de Wetering J, Berger S, Bemelman F, Kuypers D, Heidt S, Rahmel A, Claas F, Peeters P, Oberbauer R, Heemann U, Krämer BK, Eurotransplant Senior DR-compatible Program (ESDP) Study Group , Tieken I, Haasnoot G, van Meel M, Rump LC, Rosenkranz A, Horn S, Margreiter R, Schneeberger S, Oberbauer R, Pohanka E, Függer F, Mühlbacher F, Berlakovich G, Meurisse M, Weekers L, Ysebaert D, Wissing KM, Mikhalski D, Mourad M, van Biesen W, Kuypers D, Floege J, Anthuber M, Viebahn R, Schenker P, Budde K, Pratschke J, Zidek W, Melchior S, Woitas R, Strassburg CH, Hugo C, Wirth M, Schiffer M, Kribben A, Pisarski P, Fichtner-Feigl S, Haubitz M, Weimer R, Weithofer P, Fornara P, Fisher L, Sester U, Zeier M, Kliem V, Klempnauer L, Grimm MO, Kunzendorf U, Stippel D, Arns W, Mönch C, Nitschke M, Bartels M, Krämer B, Kruger B, Heemann U, Werner J, Hoyer J, Wolters HH, Suwelack B, Lutz J, Banas B, Hakenberg O, Olbricht CJ, Kalus M, Schwenger V, Nadalin S, Schröppel B, Lopau K, Seelen MAJ, Berger SP, de Fijter JW, van der Linden SJ, Christiaans MHL, van de Wetering J, van Zuilen AD, Bemelman F, Nurmohamed A, Hilbrands L: (2023) A paired-kidney allocation study found superior survival with HLA-DR compatible kidney transplants in the Eurotransplant Senior Program. Kidney Int. 2023;104(3): 552-561
Bosch A, Kannenkeril D, Ott C, Guenes-Altan M, Striepe K, Schiffer M, Schmieder RE: (2023) RELATION BETWEEN WAIST CIRCUMFERENCE AND THE RENAL HEMODYNAMIC IN PATIENTS WITH UNCOMPLICATED HYPERTENSION GRADE 1-2 J Hypertens. 2023;41 Suppl 3(): E264-E264
Bosch A, Schmid A, Kannenkeril D, Ott C, Harazny J, Striepe K, Guenes-Altan M, Schiffer M, Uder M, Schmieder RE: (2023) RENAL DENERVATION REDUCES RETINAL ARTERIAL REMODELING IN PATIENTS WITH TREATMENT RESISTANT HYPERTENSION AND TYPE 2 DIABETES MELLITUS J Hypertens. 2023;41 Suppl 3(): E296-E297
Striepe K, Schiffer M, Schmieder R: (2022) [Renal denervation : Really an alternative to reducing blood pressure?] Internist (Berl). 2022;63(3): 330-340
Sopel N, Ohs A, Schiffer M, Müller-Deile J: (2022) A Tight Control of Non-Canonical TGF-β Pathways and MicroRNAs Downregulates Nephronectin in Podocytes. Cells. 2022;11(1):
Friedrich AC, Linz P, Nagel AM, Rosenhauer D, Horn S, Schiffer M, Uder M, Kopp C, Dahlmann A: (2022) Hemodialysis Patients with Cardiovascular Disease Reveal Increased Tissue Na+ Deposition. Kidney Blood Press Res. 2022;47(3): 185-193
Birkefeld K, Bauer-Hohmann M, Klewitz F, Kyaw Tha Tun EM, Tegtbur U, Pape L, Schiffer L, Schiffer M, de Zwaan M, Nöhre M: (2022) Prevalence of Mental Disorders in a German Kidney Transplant Population: Results of a KTx360°-Substudy. J Clin Psychol Med Settings. 2022;29(4): 963-976
Protze J, Naas S, Krüger R, Stöhr C, Kraus A, Grampp S, Wiesener M, Schiffer M, Hartmann A, Wullich B, Schödel J: (2022) The renal cancer risk allele at 14q24.2 activates a novel hypoxia-inducible transcription factor-binding enhancer of DPF3 expression. J Biol Chem. 2022;298(3):
Suwelack B, Berger K, Wolters H, Gerß JWO, Bormann E, Wörmann V, Burgmer M, SoLKiD study group , Koch M, Kröncke S, Weimer R, Rainer L, Sommerer C, Zeier M, Budde K, Halleck F, Ivens K, Hansen A, Reinke P, Pascher A, Mühlfeld A, Floege J, Wahba R, Vitinius F, Kribben A, Eisenberger U, Hugo C, Quick C, Nitschke M, Derad I, Rath T, Mönch C, Schiffer M, Güler F, Krüger B, Bönnighoff R, Hauser I, Platschek S, Lopau K, Pein U, Weigand K, Feldkamp T, Kunzendorf U: (2022) Results of the prospective multicenter SoLKiD cohort study indicate bio-psycho-social outcome risks to kidney donors 12 months after donation. Kidney Int. 2022;101(3): 597-606
Scholz JK, Kraus A, Lüder D, Skoczynski K, Schiffer M, Grampp S, Schödel J, Buchholz B: (2022) Loss of Polycystin-1 causes cAMP-dependent switch from tubule to cyst formation. iScience. 2022;25(6):
Kheirkhah A, Lamina C, Kollerits B, Schachtl-Riess JF, Schultheiss UT, Forer L, Sekula P, Kotsis F, Eckardt KU, Kronenberg F, GCKD Investigators , Eckardt KU, Meiselbach H, Schneider MP, Schiffer M, Prokosch HU, Bärthlein B, Beck A, Reis A, Ekici AB, Becker S, Becker-Grosspitsch D, Alberth-Schmidt U, Hausknecht B, Weigel A, Walz G, Köttgen A, Schultheiß UT, Kotsis F, Meder S, Mitsch E, Reinhard U, Floege J, Saritas T, Schaeffner E, Baid-Agrawal S, Theisen K, Haller H, Menne J, Zeier M, Sommerer C, Theilinger J, Wolf G, Busch M, Paul R, Sitter T, Wanner C, Krane V, Börner-Klein A, Bauer B, Kronenberg F, Raschenberger J, Kollerits B, Forer L, Schönherr S, Weissensteiner H, Oefner P, Gronwald W, Schmid M, Nadal J: (2022) PCSK9 and Cardiovascular Disease in Individuals with Moderately Decreased Kidney Function. Clin J Am Soc Nephrol. 2022;17(6): 809-818

Sprechstunden

Privatsprechstunde (Prof. Dr. M. Schiffer)

Nephrologie

Privatsprechstunde

Prof. Dr. med. Mario Schiffer MBA
PD Dr. med. habil Anke Dahlmann
Dr. med. Anne Dieterle

Zeiten
nach Vereinbarung

Internistisches Zentrum (INZ)
Ulmenweg 18
91054 Erlangen

Raum
C 2 560

Kontakt für Terminvergabe
Terminvergabe nur nach Absprache

Hochschulambulanz
Montag bis Freitag
11.00 - 15.00 Uhr
Telefon: 09131 85-32566
Fax: 09131 85-33431

Hinweis

In dieser Sprechstunde werden mit allen Experten der Medizinischen Klinik 4 Patientinnen und Patienten der privaten Krankenversicherungen mit sämtlichen Nierenerkrankungen betreut.

Bitte bringen Sie vorhandene Vorbefunde mit.